Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
renal disease
Biotech
Pfizer and Flagship add Quotient to multibillion-dollar equation
Pfizer and Flagship have added Quotient into their 10-program partnership, inking a deal to discover new targets in heart and kidney diseases.
Gabrielle Masson
Aug 28, 2024 6:30am
Revivicor sees 61 days' function in kidney+thymus xenotransplant
Sep 25, 2023 9:45am
Racing Bayer, Merck gets FDA fast-track tag for anticoagulant
Aug 23, 2022 8:40am
Bayer-Ionis' anti-thrombotic med doesn't increase bleeding
Jul 28, 2022 10:51am
Sanifit lands $231M Vifor buyout ahead of phase 3 data
Nov 22, 2021 6:08am
Everest inks $561M biobucks deal for renal disease treatment
Sep 17, 2021 10:20am
